BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 25403912)

  • 1. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.
    Marchiq I; Albrengues J; Granja S; Gaggioli C; Pouysségur J; Simon MP
    Oncotarget; 2015 Sep; 6(28):24636-48. PubMed ID: 26284589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
    Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
    Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse.
    Philp NJ; Ochrietor JD; Rudoy C; Muramatsu T; Linser PJ
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1305-11. PubMed ID: 12601063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
    Baba M; Inoue M; Itoh K; Nishizawa Y
    Biochem Biophys Res Commun; 2008 Sep; 374(1):111-6. PubMed ID: 18616931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
    De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
    Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCT1, MCT4 and CD147 gene polymorphisms in healthy horses and horses with myopathy.
    Mykkänen AK; Koho NM; Reeben M; McGowan CM; Pösö AR
    Res Vet Sci; 2011 Dec; 91(3):473-7. PubMed ID: 21036377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
    Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
    Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
    Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
    Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
    Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
    Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.
    Sepponen K; Ruusunen M; Pakkanen JA; Pösö AR
    Vet J; 2007 Jul; 174(1):122-8. PubMed ID: 16901736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts.
    Pelletier J; Roux D; Viollet B; Mazure NM; Pouysségur J
    Oncotarget; 2015 May; 6(14):11833-47. PubMed ID: 26059436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.